• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Christophe Hézode, Hélène Fontaine, +35 authors Jean-Pierre Bronowicki
  • Medicine
  • Journal of hepatology
  • 2013 (First Publication: 1 September 2013)
  • BACKGROUND & AIMS In phase III trials, the safety profile of triple therapy (pegylated interferon/ribavirin with boceprevir or telaprevir) seems to be similar in HCV treatment-experienced cirrhoticContinue Reading
  • Christophe Bureau, Sophie Métivier, +7 authors Jean Pierre Vinel
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2008 (First Publication: 4 April 2008)
  • BACKGROUND Hepatic venous pressure gradient (HVPG) is a prognostic marker in patients with cirrhosis. Transient elastography measures liver stiffness (LS). AIM To assess the correlation between LSContinue Reading
  • Marie Angèle Robic, Bogdan Procopeţ, +4 authors Christophe Bureau
  • Medicine
  • Journal of hepatology
  • 2011 (First Publication: 1 March 2011)
  • BACKGROUND & AIMS The prognosis of patients with chronic liver disease is to a great extent determined by the presence and degree of portal hypertension (PHT). Hepatic venous pressure gradient (HVPG)Continue Reading
  • Armand Abergel, Tarik Asselah, +6 authors Veronique Loustaud-Ratti
  • Medicine
  • The Lancet. Infectious diseases
  • 2016 (First Publication: 1 April 2016)
  • BACKGROUND Data about the response of hepatitis C virus (HCV) genotype 5 to approved and experimental treatment regimens are scarce. We assessed the efficacy and safety of combination therapy withContinue Reading
  • Christophe Bureau, Juan Carlos García Pagán, +9 authors Jean Pierre Vinel
  • Medicine
  • Liver international : official journal of the…
  • 2007 (First Publication: 1 August 2007)
  • An 80% dysfunction rate at 2 years limits the use of transjugular intrahepatic portosystemic shunts (TIPS) in the treatment of complications of portal hypertension. The use of covered stents couldContinue Reading
  • Nassim Kamar, Olivier Marion, +9 authors Laurent Alric
  • Medicine
  • American journal of transplantation : official…
  • 2016 (First Publication: 1 May 2016)
  • There is no approved therapy for hepatitis C virus (HCV) infection after kidney transplantation, and no data regarding the use of new-generation direct antiviral agents (DAAs) have been published soContinue Reading
  • Christophe Bureau, Sophie Métivier, +9 authors Jean Pierre Vinel
  • Medicine
  • Journal of hepatology
  • 2011 (First Publication: 1 May 2011)
  • BACKGROUND & AIMS Refractory ascites in patients with cirrhosis is associated with poor survival. TIPS is more effective than paracentesis for the prevention of recurrence of ascites but increasesContinue Reading